{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:09:08Z","timestamp":1793336948397,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75098-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:34:50Z","timestamp":1782786890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the Ip6k2\u2013Runx2 axis disrupts osteoblast\u2013osteoclast coupling to treat osteoporosis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-8796","authenticated-orcid":false,"given":"Guixing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-1991","authenticated-orcid":false,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-7520","authenticated-orcid":false,"given":"Zhen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-1774","authenticated-orcid":false,"given":"Huiling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"75098_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638\u2013649 (2003).","journal-title":"Nat. Rev. Genet."},{"key":"75098_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00223-013-9790-y","volume":"94","author":"MB Schaffler","year":"2014","unstructured":"Schaffler, M. B., Cheung, W. Y., Majeska, R. & Kennedy, O. Osteocytes: master orchestrators of bone. Calcif. Tissue Int. 94, 5\u201324 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"75098_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrm3254","volume":"13","author":"F Long","year":"2012","unstructured":"Long, F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 13, 27 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75098_CR4","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1136\/ard.61.suppl_2.ii32","volume":"61","author":"DH Jones","year":"2002","unstructured":"Jones, D. H., Kong, Y. Y. & Penninger, J. M. Role of RANKL and RANK in bone loss and arthritis. Ann. Rheum. Dis. 61, ii32\u2013ii39 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"75098_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s42255-023-00948-y","volume":"6","author":"S Stegen","year":"2024","unstructured":"Stegen, S., Moermans, K., Stockmans, I., Thienpont, B. & Carmeliet, G. The serine synthesis pathway drives osteoclast differentiation through epigenetic regulation of NFATc1 expression. Nat. Metab. 6, 141\u2013152 (2024).","journal-title":"Nat. Metab."},{"key":"75098_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41413-018-0035-6","volume":"6","author":"X Chen","year":"2018","unstructured":"Chen, X., Zhi, X., Wang, J. & Su, J. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 6, 34 (2018).","journal-title":"Bone Res."},{"key":"75098_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","volume":"561","author":"Y Ikebuchi","year":"2018","unstructured":"Ikebuchi, Y. et al. Coupling of bone resorption and formation by RANKL reverse signalling. Nature 561, 195\u2013200 (2018).","journal-title":"Nature"},{"key":"75098_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41413-018-0040-9","volume":"6","author":"X Cao","year":"2018","unstructured":"Cao, X. RANKL-RANK signaling regulates osteoblast differentiation and bone formation. Bone Res. 6, 35 (2018).","journal-title":"Bone Res."},{"key":"75098_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14003-6","volume":"11","author":"MM Weivoda","year":"2020","unstructured":"Weivoda, M. M. et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nat. Commun. 11, 87 (2020).","journal-title":"Nat. Commun."},{"key":"75098_CR10","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.2499","volume":"17","author":"X Cao","year":"2011","unstructured":"Cao, X. Targeting osteoclast-osteoblast communication. Nat. Med. 17, 1344\u20131346 (2011).","journal-title":"Nat. Med."},{"key":"75098_CR11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.2489","volume":"17","author":"T Negishi-Koga","year":"2011","unstructured":"Negishi-Koga, T. et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. 17, 1473\u20131480 (2011).","journal-title":"Nat. Med."},{"key":"75098_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115628","volume":"141","author":"JM Delaisse","year":"2020","unstructured":"Delaisse, J. M. et al. Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone 141, 115628 (2020).","journal-title":"Bone"},{"key":"75098_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","volume":"12","author":"BM El-Masri","year":"2024","unstructured":"El-Masri, B. M. et al. Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res. 12, 62 (2024).","journal-title":"Bone Res."},{"key":"75098_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","volume":"10","author":"MM Winslow","year":"2006","unstructured":"Winslow, M. M. et al. Calcineurin\/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771\u2013782 (2006).","journal-title":"Dev. Cell"},{"key":"75098_CR15","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1172\/JCI35711","volume":"118","author":"AO Aliprantis","year":"2008","unstructured":"Aliprantis, A. O. et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Investig. 118, 3775\u20133789 (2008).","journal-title":"J. Clin. Investig."},{"key":"75098_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm1270","volume":"11","author":"T Koga","year":"2005","unstructured":"Koga, T. et al. NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880\u2013885 (2005).","journal-title":"Nat. Med."},{"key":"75098_CR17","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1172\/JCI42106","volume":"120","author":"H Cao","year":"2010","unstructured":"Cao, H. et al. Activating transcription factor 4 regulates osteoclast differentiation in mice. J. Clin. Invest. 120, 2755\u20132766 (2010).","journal-title":"J. Clin. Invest."},{"key":"75098_CR18","doi-asserted-by":"publisher","first-page":"47109","DOI":"10.1074\/jbc.M410010200","volume":"279","author":"X Yang","year":"2004","unstructured":"Yang, X. & Karsenty, G. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279, 47109\u201347114 (2004).","journal-title":"J. Biol. Chem."},{"key":"75098_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115864","volume":"169","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Advances in the roles of ATF4 in osteoporosis. Biomed. Pharmacother. 169, 115864 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"75098_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","volume":"4","author":"F Elefteriou","year":"2006","unstructured":"Elefteriou, F. et al. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasia. Cell Metab. 4, 441\u2013451 (2006).","journal-title":"Cell Metab."},{"key":"75098_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","volume":"89","author":"T Komori","year":"1997","unstructured":"Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755\u2013764 (1997).","journal-title":"Cell"},{"key":"75098_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","volume":"89","author":"F Otto","year":"1997","unstructured":"Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765\u2013771 (1997).","journal-title":"Cell"},{"key":"75098_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W","volume":"214","author":"M Inada","year":"1999","unstructured":"Inada, M. et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214, 279\u2013290 (1999).","journal-title":"Dev. Dyn."},{"key":"75098_CR24","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1074\/jbc.275.12.8695","volume":"275","author":"H Enomoto","year":"2000","unstructured":"Enomoto, H. et al. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem. 275, 8695\u20138702 (2000).","journal-title":"J. Biol. Chem."},{"key":"75098_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.153.1.87","volume":"153","author":"C Ueta","year":"2001","unstructured":"Ueta, C. et al. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153, 87\u2013100 (2001).","journal-title":"J. Cell Biol."},{"key":"75098_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1101\/gad.845101","volume":"15","author":"S Takeda","year":"2001","unstructured":"Takeda, S., Bonnamy, J. P., Owen, M. J., Ducy, P. & Karsenty, G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467\u2013481 (2001).","journal-title":"Genes Dev."},{"key":"75098_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00418-018-1640-6","volume":"149","author":"T Komori","year":"2018","unstructured":"Komori, T. Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem. Cell Biol. 149, 313\u2013323 (2018).","journal-title":"Histochem. Cell Biol."},{"key":"75098_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ydbio.2011.11.013","volume":"362","author":"X Tu","year":"2012","unstructured":"Tu, X., Joeng, K. S. & Long, F. Indian hedgehog requires additional effectors besides Runx2 to induce osteoblast differentiation. Dev. Biol. 362, 76\u201382 (2012).","journal-title":"Dev. Biol."},{"key":"75098_CR29","first-page":"211","volume":"143","author":"T Takarada","year":"2016","unstructured":"Takarada, T. et al. Genetic analysis of Runx2 function during intramembranous ossification. Development 143, 211\u2013218 (2016).","journal-title":"Development"},{"key":"75098_CR30","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1101\/gad.1174704","volume":"18","author":"CA Yoshida","year":"2004","unstructured":"Yoshida, C. A. et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 18, 952\u2013963 (2004).","journal-title":"Genes Dev."},{"key":"75098_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-020-00666-7","volume":"106","author":"Y Xin","year":"2020","unstructured":"Xin, Y. et al. New function of RUNX2 in regulating osteoclast differentiation via the AKT\/NFATc1\/CTSK axis. Calcif. Tissue Int. 106, 553\u2013566 (2020).","journal-title":"Calcif. Tissue Int."},{"key":"75098_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.120.313791","volume":"41","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Zhao, X. & Wu, H. Transcriptional programming in arteriosclerotic disease: a multifaceted function of the Runx2 (runt-related transcription factor 2). Arterioscler. Thromb. Vasc. Biol. 41, 20\u201334 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"75098_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2148-10-78","volume":"10","author":"S Marcellini","year":"2010","unstructured":"Marcellini, S. et al. Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis. BMC Evolut. Biol. 10, 78 (2010).","journal-title":"BMC Evolut. Biol."},{"key":"75098_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.100027","volume":"763","author":"GL Galea","year":"2020","unstructured":"Galea, G. L. et al. Mechanical strain-mediated reduction in RANKL expression is associated with RUNX2 and BRD2. Gene 763, 100027 (2020).","journal-title":"Gene"},{"key":"75098_CR35","doi-asserted-by":"publisher","first-page":"23971","DOI":"10.1074\/jbc.M302457200","volume":"278","author":"H Enomoto","year":"2003","unstructured":"Enomoto, H. et al. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-\/- mice by RANKL transgene. J. Biol. Chem. 278, 23971\u201323977 (2003).","journal-title":"J. Biol. Chem."},{"key":"75098_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2021.100088","volume":"12","author":"H Rashid","year":"2021","unstructured":"Rashid, H., Chen, H. & Javed, A. Runx2 is required for hypertrophic chondrocyte mediated degradation of cartilage matrix during endochondral ossification. Matrix Biol. 12, 100088 (2021).","journal-title":"Matrix Biol."},{"key":"75098_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6953421","volume":"2020","author":"L Zhong","year":"2020","unstructured":"Zhong, L., Yuan, J., Huang, L., Li, S. & Deng, L. RANKL is involved in Runx2-triggered hepatic infiltration of macrophages in mice with NAFLD induced by a high-fat diet. Biomed. Res. Int. 2020, 6953421 (2020).","journal-title":"Biomed. Res. Int."},{"key":"75098_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong, Y. Y. et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304\u2013309 (1999).","journal-title":"Nature"},{"key":"75098_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong, Y. Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315\u2013323 (1999).","journal-title":"Nature"},{"key":"75098_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa, N. et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J. Bone Min. Metab. 39, 19\u201326 (2021).","journal-title":"J. Bone Min. Metab."},{"key":"75098_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"75098_CR42","first-page":"666","volume":"123","author":"S Lotinun","year":"2013","unstructured":"Lotinun, S. et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Invest. 123, 666\u2013681 (2013).","journal-title":"J. Clin. Invest."},{"key":"75098_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","volume":"581","author":"X Han","year":"2020","unstructured":"Han, X. et al. Construction of a human cell landscape at single-cell level. Nature 581, 303\u2013309 (2020).","journal-title":"Nature"},{"key":"75098_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","volume":"562","author":"C Tabula Muris","year":"2018","unstructured":"Tabula Muris, C. et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562, 367\u2013372 (2018).","journal-title":"Nature"},{"key":"75098_CR45","doi-asserted-by":"publisher","first-page":"70916","DOI":"10.18632\/oncotarget.20200","volume":"8","author":"MS Kim","year":"2017","unstructured":"Kim, M. S., Gernapudi, R., Choi, E. Y., Lapidus, R. G. & Passaniti, A. Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity. Oncotarget 8, 70916\u201370940 (2017).","journal-title":"Oncotarget"},{"key":"75098_CR46","doi-asserted-by":"publisher","unstructured":"Ma, G. et al. The p53-miR17 family-Rankl axis bridges liver-bone communication. Mol. Therapy. https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.046 (2024).","DOI":"10.1016\/j.ymthe.2024.12.046"},{"key":"75098_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04715-x","volume":"13","author":"C Shao","year":"2022","unstructured":"Shao, C. et al. LPS\/Bcl3\/YAP1 signaling promotes Sox9(+)HNF4alpha(+) hepatocyte-mediated liver regeneration after hepatectomy. Cell Death Dis. 13, 277 (2022).","journal-title":"Cell Death Dis."},{"key":"75098_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-018-0554-8","volume":"562","author":"S Debnath","year":"2018","unstructured":"Debnath, S. et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature 562, 133\u2013139 (2018).","journal-title":"Nature"},{"key":"75098_CR49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","volume":"130","author":"T Nakamura","year":"2007","unstructured":"Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811\u2013823 (2007).","journal-title":"Cell"},{"key":"75098_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/gene.20041","volume":"39","author":"WS Chiu","year":"2004","unstructured":"Chiu, W. S. et al. Transgenic mice that express Cre recombinase in osteoclasts. Genesis 39, 178\u2013185 (2004).","journal-title":"Genesis"},{"key":"75098_CR51","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180\u2013D1192 (2024).","journal-title":"Nucleic Acids Res."},{"key":"75098_CR52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.str.2020.11.012","volume":"29","author":"C Hou","year":"2021","unstructured":"Hou, C., Mandal, A., Rohr, J. & Tsodikov, O. V. Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. Structure 29, 404\u2013412.e404 (2021).","journal-title":"Structure"},{"key":"75098_CR53","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1021\/acs.jmedchem.2c00220","volume":"65","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Development of novel IP6K inhibitors for the treatment of obesity and obesity-induced metabolic dysfunctions. J. Med. Chem. 65, 6869\u20136887 (2022).","journal-title":"J. Med. Chem."},{"key":"75098_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24934-8","volume":"12","author":"Y Moritoh","year":"2021","unstructured":"Moritoh, Y. et al. The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals. Nat. Commun. 12, 4847 (2021).","journal-title":"Nat. Commun."},{"key":"75098_CR55","doi-asserted-by":"publisher","unstructured":"Dilworth, L., Stennett, D. & Omoruyi, F. Cellular and molecular activities of IP6 in disease prevention and therapy. Biomolecules 13 https:\/\/doi.org\/10.3390\/biom13060972 (2023).","DOI":"10.3390\/biom13060972"},{"key":"75098_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-biochem-030222-121901","volume":"93","author":"L Nagpal","year":"2024","unstructured":"Nagpal, L., He, S., Rao, F. & Snyder, S. H. Inositol pyrophosphates as versatile metabolic messengers. Annu. Rev. Biochem. 93, 317\u2013338 (2024).","journal-title":"Annu. Rev. Biochem."},{"key":"75098_CR57","doi-asserted-by":"publisher","unstructured":"Aguirre, T. et al. An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor. eLife 12, https:\/\/doi.org\/10.7554\/eLife.88982 (2023).","DOI":"10.7554\/eLife.88982"},{"key":"75098_CR58","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.1074\/jbc.M900752200","volume":"284","author":"U Padmanabhan","year":"2009","unstructured":"Padmanabhan, U., Dollins, D. E., Fridy, P. C., York, J. D. & Downes, C. P. Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates. J. Biol. Chem. 284, 10571\u201310582 (2009).","journal-title":"J. Biol. Chem."},{"key":"75098_CR59","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1073\/pnas.1424642112","volume":"112","author":"F Rao","year":"2015","unstructured":"Rao, F. et al. Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1. Proc. Natl. Acad. Sci. USA 112, 1773\u20131778 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75098_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2193866","volume":"38","author":"M Ahn","year":"2023","unstructured":"Ahn, M. et al. Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors. J. Enzym. Inhibit. Med. Chem. 38, 2193866 (2023).","journal-title":"J. Enzym. Inhibit. Med. Chem."},{"key":"75098_CR61","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1073\/pnas.0711168105","volume":"105","author":"A Chakraborty","year":"2008","unstructured":"Chakraborty, A. et al. HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. Proc. Natl. Acad. Sci. USA 105, 1134\u20131139 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75098_CR62","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1073\/pnas.0711993105","volume":"105","author":"DS Shames","year":"2008","unstructured":"Shames, D. S. & Minna, J. D. IP6K2 is a client for HSP90 and a target for cancer therapeutics development. Proc. Natl. Acad. Sci. USA 105, 1389\u20131390 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75098_CR63","doi-asserted-by":"publisher","unstructured":"Minini, M., Senni, A., Unfer, V. & Bizzarri, M. The key role of IP(6)K: a novel target for anticancer treatments? Molecules 25, https:\/\/doi.org\/10.3390\/molecules25194401 (2020).","DOI":"10.3390\/molecules25194401"},{"key":"75098_CR64","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro\u2013computed tomography. J. Bone Miner. Res. 25, 1468\u20131486 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"75098_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100062","volume":"1","author":"AE Sullivan","year":"2020","unstructured":"Sullivan, A. E. & Santos, S. D. M. An Optimized protocol for ChIP-Seq from human embryonic stem cell cultures. STAR Protoc. 1, 100062 (2020).","journal-title":"STAR Protoc."},{"key":"75098_CR66","doi-asserted-by":"publisher","unstructured":"Fu, X. et al. Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice. Signal Transduct. Target. Therapy 5, https:\/\/doi.org\/10.1038\/s41392-020-00328-y (2020).","DOI":"10.1038\/s41392-020-00328-y"},{"key":"75098_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101639","volume":"298","author":"Q Yan","year":"2022","unstructured":"Yan, Q., Gao, H., Yao, Q., Ling, K. & Xiao, G. Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling. J. Biol. Chem. 298, 101639 (2022).","journal-title":"J. Biol. Chem."},{"key":"75098_CR68","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s42255-021-00468-7","volume":"3","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. 5-IP7 is a GPCR messenger mediating neural control of synaptotagmin-dependent insulin exocytosis and glucose homeostasis. Nat. Metab. 3, 1400\u20131414 (2021).","journal-title":"Nat. Metab."},{"key":"75098_CR69","doi-asserted-by":"publisher","unstructured":"Cao, H. et al. Focal adhesion protein Kindlin-2 regulates bone homeostasis in mice. Bone Res. 8, https:\/\/doi.org\/10.1038\/s41413-019-0073-8 (2020).","DOI":"10.1038\/s41413-019-0073-8"},{"key":"75098_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14186-y","volume":"11","author":"K Zhu","year":"2020","unstructured":"Zhu, K. et al. Kindlin-2 modulates MafA and \u03b2-catenin expression to regulate \u03b2-cell function and mass in mice. Nat. Commun. 11, 484 (2020).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75098-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75098-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75098-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:04:05Z","timestamp":1786446245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75098-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75098"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75098-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8130"}}